Quantumzyme Corp. 8-K

What Happened Quantumzyme Corp. announced that on November 30, 2025 its Board of Directors approved an amendment to the Articles of Incorporation to change the company name to Quantum Genesis AI Corp. A holder of a majority of the voting power of outstanding stock approved the name change by written consent on the same date. The company has not yet filed the Certificate of Amendment with the Nevada Secretary of State; that filing will follow completion of the Schedule 14C information statement process and the expiration of the applicable 20‑day federal waiting period.

Key Details

• Board and majority shareholder approval granted on November 30, 2025.
• Certificate of Amendment not yet filed with Nevada; filing to occur after Schedule 14C process and 20‑day waiting period.
• Company filed an Issuer Company‑Related Action Notification with FINRA to reflect the name change and request a new ticker symbol.
• Name change will not alter shareholder rights, authorized capital, issued/outstanding shares, CUSIP, or par value.

Why It Matters A corporate name change is a cosmetic but visible corporate action that can affect ticker recognition and branding; investors should note the change is not effective until required filings and regulatory reviews are complete. There is no change to capital structure or shareholder rights per the filing. Monitor future company filings and FINRA communications for the effective date and any new ticker symbol.